The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Industries Direct’s proprietary databases, Domain Therapeutics’s corporate website, SEC filings, investor presentations and featured press releases, both from Domain Therapeutics and market -specific third party sources, put together by Global Industries Direct’s team.

Scope of the Research

- Domain Therapeutics - Brief Domain Therapeutics overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Domain Therapeutics human therapeutic division.
- Detailed Analysis of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Domain Therapeutics with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Domain Therapeutics’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Why Should You Get This Report?

- Evaluate Domain Therapeutics’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Domain Therapeutics in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Domain Therapeutics’s Research and Development portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Domain Therapeutics.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Domain Therapeutics and identify potential opportunities in those areas.

Table Of Contents

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Domain Therapeutics Snapshot 5
Domain Therapeutics Overview 5
Key Information 5
Key Facts 5
Domain Therapeutics - Research and Development Overview 6
Key Therapeutic Areas 6
Domain Therapeutics - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Domain Therapeutics - Pipeline Products Glance 10
Domain Therapeutics - Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Discovery Products/Combination Treatment Modalities 11
Domain Therapeutics - Drug Profiles 12
DT0738 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
DT1133 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
DT1687 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
DT2228 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
GLP-1R PAMs 16
Product Description 16
Mechanism of Action 16
RandD Progress 16
Orphan GPCR 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
Domain Therapeutics - Pipeline Analysis 18
Domain Therapeutics - Pipeline Products by Therapeutic Class 18
Domain Therapeutics - Pipeline Products By Target 19
Domain Therapeutics - Pipeline Products by Route of Administration 20
Domain Therapeutics - Pipeline Products by Molecule Type 21
Domain Therapeutics - Dormant Projects 22
Domain Therapeutics - Locations And Subsidiaries 23
Head Office 23
Company's Recent Developments 24
Domain Therapeutics, Recent Developments 24
January 27, 2004: Faust Pharmaceuticals SA, Initiates A Phase I Clinical Trial Of FP0011 24
April 26, 2006: Faust Pharmaceuticals SA Announces Phase IIa Clinical Trial Results For Treatment Of Amyotrophic Lateral Sclerosis (ALS) 24
April 26, 2004: Faust Pharmaceuticals SA Announces Phase IIa Clinical Trial Results For Treatment Of Amyotrophic Lateral Sclerosis (ALS) 25
June 06, 2007: Faust Pharmaceuticals Phase IIa Results for Parkinson's Disease Presented At International Congress Of Parkinson's Disease And Movement Disorders 26
Financial Deals Landscape 27
Domain Therapeutics, Deals Summary 27
Domain Therapeutics, Pharmaceuticals and Healthcare, Deal Details 28
Venture Financing 28
Domain Therapeutics Secures US$ 3 Mln In Venture Financing Round 28
Faust Pharmaceuticals Secures US$ 10 Mln In Series C Financing Round 30
Faust Pharmaceuticals Raises US$ 18.9 Mln In Series B Financing 32
Partnerships 34
Domain Therapeutics Enters Into Research Agreement With Takeda Pharmaceutical 34
Domain Therapeutics Enters Into Research Agreement With Takeda 35
Licensing Agreements 36
Domain Therapeutics Enters Into Licensing Agreement With Merck Serono 36
Appendix 38
Methodology 38
Coverage 38
Secondary Research 38
Primary Research 39
Expert Panel Validation 39
Contact Us 39
Disclaimer 39

List of Tables

Domain Therapeutics, Facts and Figures 5
Domain Therapeutics, Key Facts 5
Domain Therapeutics - Pipeline by Therapy Area and Indication, H2 2011 7
Domain Therapeutics - Pipeline by Stage of Development, H2 2011 8
Domain Therapeutics - Monotherapy Products in Pipeline, H2 2011 9
Domain Therapeutics - Pre-Clinical, H2 2011 10
Domain Therapeutics - Discovery, H2 2011 11
Domain Therapeutics - Pipeline By Therapeutic Class, H2 2011 18
Domain Therapeutics - Pipeline By Target, H2 2011 19
Domain Therapeutics - Pipeline By Route of Administration, H2 2011 20
Domain Therapeutics - Pipeline By Molecule Type, H2 2011 21
Domain Therapeutics - Dormant Developmental Projects, 2010 22
Domain Therapeutics, Deals Summary 27
Domain Therapeutics Secures US$ 3 Mln In Venture Financing Round 28
Faust Pharmaceuticals Secures US$ 10 Mln In Series C Financing Round 30
Faust Pharmaceuticals Raises US$ 18.9 Mln In Series B Financing 32
Domain Therapeutics Enters Into Research Agreement With Takeda Pharmaceutical 34
Domain Therapeutics Enters Into Research Agreement With Takeda 35
Domain Therapeutics Enters Into Licensing Agreement With Merck Serono 36

List of Figures

Domain Therapeutics - Pipeline by Therapy Area and Indication, H2 2011 7
Domain Therapeutics - Pipeline by Stage of Development, H2 2011 8
Domain Therapeutics - Monotherapy Products in Pipeline, H2 2011 9
Domain Therapeutics - Pipeline By Therapeutic Class, H2 2011 18
Domain Therapeutics - Pipeline By Target, H2 2011 19

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014

  • $ 2 500
  • Company report
  • June 2014
  • by Global Markets Direct

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Inflammation - Pipeline Review, H1 2014', provides an overview of the Inflammation's therapeutic pipeline. This report provides ...

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • April 2014
  • by Global Markets Direct

Corcept Therapeutics Incorporated - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Corcept Therapeutics Incorporated - Product Pipeline Review - 2014', provides an overview of the Corcept ...

Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

Pharmaceutical in United States: ImmunoCellular Therapeutics, Ltd. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the ImmunoCellular Therapeutics, Ltd.’s research and development focus. The report includes information on current developmental ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.